Efficacy and Safety of Caspofungin in Primary Prophylaxis of Invasive Fungal Disease in Patients with Hematopoietic Stem Cell Transplantation
-
Published:2022
Issue:01
Volume:12
Page:30-39
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference34 articles.
1. 郑珊珊, 郭智, 陈丽娜, 刘玄勇, 陈丽萍, 黄嘉谊, 等. 血液肿瘤患者侵袭性真菌病经验治疗与诊断驱动治疗的对比研究[J]. 国际肿瘤学杂志, 2019, 46(7): 410-414.
2. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
3. High-Dose Caspofungin as a Component of Combination Antifungal Therapy in 91 Patients With Neoplastic Diseases and Hematopoietic Stem Cell Transplantation
4. Bridging antifungal prophylaxis with micafungin in hematopoietic stem cell transplantation: a retrospective analysis
5. The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models